We only have this paper's title and publication details.
Read it at the sourceLoss of Smad4 alters secretome and promotes pancreatic cancer progression, suggesting TGFβ inhibition could be impacted.
Loss of Smad4 alters the secretome of pancreatic cancer cells
No takes yet. Share an insight, caveat, or question.
Murimwa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: